Gandawan, Tarhata M.
HRN: 13-93-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/25/2024
10/09/2024
IV
4.5gms
Q8
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes